{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:54:13Z","timestamp":1790902453617,"version":"4.1.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Medical Science Research Project of Hebei","award":["20242051"],"award-info":[{"award-number":["20242051"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11606-025-09904-w","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T19:27:30Z","timestamp":1759433250000},"page":"506-515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Correlation Between Serum Uric Acid and Metabolic Dysfunction-Associated Fatty Liver Disease: An Updated Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"41","author":[{"given":"Shuanghao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zechao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4182-7244","authenticated-orcid":false,"given":"Xiangming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"issue":"1","key":"9904_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.21037\/hbsn-23-556","volume":"13","author":"T-W Lou","year":"2024","unstructured":"Lou T-W et al. The global burden of fatty liver disease: the major impact of China. Hepatobiliary Surg Nutr. 2024;13(1):119-123.","journal-title":"Hepatobiliary Surg Nutr."},{"issue":"1","key":"9904_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","volume":"129","author":"LA Adams","year":"2005","unstructured":"Adams LA et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129(1):113-21.","journal-title":"Gastroenterol."},{"issue":"4","key":"9904_CR3","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/hep.21327","volume":"44","author":"M Ekstedt","year":"2006","unstructured":"Ekstedt M et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatol (Baltimore, Md.). 2006;44(4):865-73.","journal-title":"Hepatol (Baltimore, Md.)"},{"issue":"1","key":"9904_CR4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jhep.2008.10.010","volume":"50","author":"J-G Fan","year":"2009","unstructured":"Fan J-G, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatology. 2009;50(1):204-10.","journal-title":"J Hepatol."},{"issue":"Suppl 4","key":"9904_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/jgh.12251","volume":"28","author":"T Miyake","year":"2013","unstructured":"Miyake T et al. Non-alcoholic fatty liver disease: factors associated with its presence and onset. J Gastroenterol Hepatol. 2013;28(Suppl 4):71-8.","journal-title":"J Gastroenterol Hepatol."},{"issue":"17","key":"9904_CR6","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI et al. Uric acid and cardiovascular risk. New England J Med. 2008;359(17):1811-21.","journal-title":"New England J Med."},{"issue":"4","key":"9904_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/ar2761","volume":"11","author":"AL Gaffo","year":"2009","unstructured":"Gaffo AL et al. Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?. Arthritis Res Ther. 2009;11(4):240.","journal-title":"Arthritis Res Ther."},{"issue":"2","key":"9904_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/BOR.0b013e3283257b96","volume":"21","author":"N Edwards","year":"2009","unstructured":"Edwards N. The role of hyperuricemia in vascular disorders. Curr Opin Rheumatol. 2009;21,(2):132-7.","journal-title":"Curr Opin Rheumatol."},{"issue":"2","key":"9904_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1515\/CCLM.2010.037","volume":"48","author":"Y-J Lee","year":"2010","unstructured":"Lee Y-J et al. Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults. Clin Chem Lab Med. 2010;48(2):175-80.","journal-title":"Clin Chem Lab Med."},{"issue":"7","key":"9904_CR10","doi-asserted-by":"publisher","first-page":"e11578","DOI":"10.1371\/journal.pone.0011578","volume":"5","author":"C Xu","year":"2010","unstructured":"Xu C et al. High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study. PloS One. 5,7 e11578. 14 Jul. 2010.","journal-title":"PloS One."},{"issue":"7","key":"9904_CR11","doi-asserted-by":"publisher","first-page":"e67152","DOI":"10.1371\/journal.pone.0067152","volume":"8","author":"Y Xie","year":"2013","unstructured":"Xie Y et al. Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men. PloS One. 2013;8(7):e67152.","journal-title":"PloS One."},{"issue":"3","key":"9904_CR12","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.metabol.2012.08.013","volume":"62","author":"JC Sirota","year":"2013","unstructured":"Sirota JC et al. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey. Metabolism: Clinical And Experimental\u00a0vol. 62,3 (2013): 392-9.","journal-title":"Metab: Clin Exp"},{"issue":"2","key":"9904_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/hep.23717","volume":"52","author":"A Afzali","year":"2010","unstructured":"Afzali A et al. Association between serum uric acid level and chronic liver disease in the United States. Hepatol (Baltimore, Md.). 2010 52(2):578-89.","journal-title":"Hepatol (Baltimore, Md.)."},{"issue":"1","key":"9904_CR14","doi-asserted-by":"publisher","first-page":"10072","DOI":"10.1038\/s41598-020-66931-9","volume":"10","author":"T Bao","year":"2020","unstructured":"Bao T et al. Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Nonobese Postmenopausal Women: A Cross-sectional Study. Sci Rep. 2020 10(1):10072.","journal-title":"Sci Rep."},{"issue":"3","key":"9904_CR15","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3346\/jkms.2011.26.3.386","volume":"26","author":"I-C Hwang","year":"2011","unstructured":"Hwang I-C et al. The relationship between normal serum uric acid and nonalcoholic fatty liver disease. J Korean Med Sci.2011;26(3):386-91.","journal-title":"J Korean Med Sci."},{"key":"9904_CR16","first-page":"3805372","volume":"2016","author":"N Fan","year":"2016","unstructured":"Fan N et al. Sex-Specific Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients. J Diab Res. 2016; 2016:3805372.","journal-title":"J Diab Res."},{"issue":"6","key":"9904_CR17","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/GME.0000000000000352","volume":"22","author":"Z Wang","year":"2015","unstructured":"Wang Z et al. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index. Menopause (New York, N.Y.). 2015;22(6):667-73.","journal-title":"Menopause (New York, N.Y.)."},{"issue":"2","key":"9904_CR18","first-page":"136","volume":"49","author":"G Darmawan","year":"2017","unstructured":"Darmawan G et al. Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis. Acta Medica Indonesiana. 2017. 49(2):136-147.","journal-title":"Acta Medica Indonesiana."},{"issue":"2","key":"9904_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/MEG.0000000000000507","volume":"28","author":"S Gong","year":"2016","unstructured":"Gong S et al. Hyperuricemia and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2016;28(2):132-8.","journal-title":"Eur J Gastroenterol Hepatol."},{"issue":"2","key":"9904_CR20","first-page":"334","volume":"26","author":"F Huang","year":"2017","unstructured":"Huang F et al. Serum uric acid levels in non-alcoholic steatosis patients: a meta-analysis. Asia Pacific J Clin Nutr. 2017;26(2):334-342.","journal-title":"Asia Pacific J Clin Nutr."},{"key":"9904_CR21","doi-asserted-by":"publisher","first-page":"14325","DOI":"10.1038\/srep14325","volume":"5","author":"Z Liu","year":"2015","unstructured":"Liu Z et al. Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Meta-analysis of Prospective Studies. Sci Rep. 2015;5:14325.","journal-title":"Sci Rep."},{"issue":"6","key":"9904_CR22","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/liv.13329","volume":"37","author":"K Wijarnpreecha","year":"2017","unstructured":"Wijarnpreecha K et al. Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis. Liver Int: Off J Int Assoc Study Liver. 2017;37(6):906-918.","journal-title":"Liver Int: Off J Int Assoc Study Liver."},{"issue":"7\u20138","key":"9904_CR23","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.clinbiochem.2015.12.010","volume":"49","author":"Y Zhou","year":"2016","unstructured":"Zhou Y et al. High serum uric acid and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis. Clin Biochem. 2016;49(7-8):636-42.","journal-title":"Clin Biochem."},{"key":"9904_CR24","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2147\/CLEP.S403314","volume":"15","author":"Q Sun","year":"2023","unstructured":"Sun Q et al. Association Between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Meta-Analysis. Clin Epidemiol. 2023;15:683-693.","journal-title":"Clin Epidemiol."},{"issue":"2","key":"9904_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/MEG.0000000000000507","volume":"28","author":"S Gong","year":"2016","unstructured":"Gong S et al. Hyperuricemia and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2016;28(2):132-8.","journal-title":"Eur J Gastroenterol Hepatol."},{"issue":"2","key":"9904_CR26","first-page":"136","volume":"49","author":"G Darmawan","year":"2017","unstructured":"Darmawan G et al. Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis. Acta M Indonesiana. 2017;49(2):136-147.","journal-title":"Acta M Indonesiana."},{"key":"9904_CR27","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet (London, England). 2016;387(10027):1513\u20131530."},{"issue":"9945","key":"9904_CR28","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","volume":"384","author":"M Ng","year":"2014","unstructured":"Ng M et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2014;384(9945):766-81.","journal-title":"Lancet (London, England)."},{"issue":"4","key":"9904_CR29","first-page":"232","volume":"7","author":"YZ Shi","year":"2021","unstructured":"Shi YZ, Shan XD, Chu XH, et al. Correlation between serum uric acid level and severity of non-alcoholic fatty liver disease in obese population [J\/CD]. J Obes Metab Dis. 2021;7(4):232-238.","journal-title":"J Obes Metab Dis."},{"key":"9904_CR30","doi-asserted-by":"crossref","unstructured":"Liu PJ et al. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women. Climacteric: The J Int Menopause Soc. 2014;17(6):692\u20139.","DOI":"10.3109\/13697137.2014.926323"},{"issue":"7","key":"9904_CR31","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1365-2036.2011.04788.x","volume":"34","author":"S Petta","year":"2011","unstructured":"Petta S et al. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011;34(7):757-66.","journal-title":"Aliment Pharmacol Ther."},{"issue":"3","key":"9904_CR32","doi-asserted-by":"publisher","first-page":"378","DOI":"10.5009\/gnl.2010.4.3.378","volume":"4","author":"JW Lee","year":"2010","unstructured":"Lee JW et al. Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver. 2010;4(3):378-83.","journal-title":"Gut Liver."},{"issue":"5","key":"9904_CR33","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","volume":"67","author":"UM Khosla","year":"2005","unstructured":"Khosla UM et al. \u201cHyperuricemia induces endothelial dysfunction. Kidney Int. 2005;67(5):1739-42.","journal-title":"Kidney Int."},{"issue":"48","key":"9904_CR34","doi-asserted-by":"publisher","first-page":"40732","DOI":"10.1074\/jbc.M112.399899","volume":"287","author":"MA Lanaspa","year":"2012","unstructured":"Lanaspa M A et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012;287(48):40732-44.","journal-title":"J Biol Chem."},{"issue":"4","key":"9904_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1179\/1351000213Y.0000000050","volume":"18","author":"F Ucar","year":"2013","unstructured":"Ucar F et al. The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis. Redox Report: Commun Free Radic Res. 2013;18(4):127-33.","journal-title":"Redox Report: Commun Free Radic Res."},{"issue":"7","key":"9904_CR36","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1111\/liv.12523","volume":"34","author":"Z Tariq","year":"2014","unstructured":"Tariq Z et al. Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)?. Liver Int: Off J Int Assoc Study Liver. 2014;34(7):e180-90.","journal-title":"Liver Int: Off J Int Assoc Study Liver."},{"issue":"46","key":"9904_CR37","first-page":"3260","volume":"87","author":"M Wang","year":"2007","unstructured":"Wang M et al. Correlation between serum uric acid and insulin resistance. Zhonghua Yi Xue Za Zhi. 2007;87(46):3260-3.","journal-title":"Zhonghua Yi Xue Za Zhi."},{"issue":"2","key":"9904_CR38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s11926-011-0162-1","volume":"13","author":"F Ghaemi-Oskouie","year":"2011","unstructured":"Ghaemi-Oskouie F, Shi Y. The role of uric acid as an endogenous danger signal in immunity and inflammation. Curr Rheumatol Rep. 2011;13(2):160-6.","journal-title":"Curr Rheumatol Rep."},{"issue":"10","key":"9904_CR39","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/eurheartj\/ehi879","volume":"27","author":"C Ruggiero","year":"2006","unstructured":"Ruggiero C et al. Uric acid and inflammatory markers. Eur Heart J. 2006;27(10):1174-81.","journal-title":"Eur Heart J."},{"issue":"3","key":"9904_CR40","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1530\/JOE-13-0201","volume":"218","author":"M Asrih","year":"2013","unstructured":"Asrih M, Jornayvaz FR. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrinol. 2013;218(3):R25-36.","journal-title":"J Endocrinol."},{"issue":"5","key":"9904_CR41","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/hep.25539","volume":"55","author":"R Lomonaco","year":"2012","unstructured":"Lomonaco R et al. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatol (Baltimore, Md.). 2012;55(5):1389-97.","journal-title":"Hepatol (Baltimore, Md.)"},{"issue":"21","key":"9904_CR42","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1001\/jama.1991.03470210076036","volume":"266","author":"F Facchini","year":"1991","unstructured":"Facchini F et al. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA. 1991;266(21):3008-11.","journal-title":"JAMA."},{"issue":"6","key":"9904_CR43","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.jhep.2015.01.019","volume":"62","author":"C Xu","year":"2015","unstructured":"Xu C et al. Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds. J Hepatol. 2015;62(6):1412-9.","journal-title":"J Hepatol."},{"issue":"4","key":"9904_CR44","first-page":"271","volume":"26","author":"JX Bai","year":"2018","unstructured":"Bai JX, Shu RM, Huang Y, Peng Z. Correlation between serum uric acid and risk of new-onset nonalcoholic fatty liver disease: a 5-year observational cohort study. Zhonghua Gan Zang Bing Za Zhi. 2018;26(4):271-275. Chinese.","journal-title":"Zhonghua Gan Zang Bing Za Zhi."},{"issue":"8","key":"9904_CR45","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1590\/S0004-27302013000800006","volume":"57","author":"W Cai","year":"2013","unstructured":"Cai W et al. Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China. Arquivos Brasileiros de Endocrinologia E Metabologia. 2013;57(8):617-22.","journal-title":"Arquivos Brasileiros de Endocrinologia E Metabologia."},{"key":"9904_CR46","doi-asserted-by":"publisher","first-page":"e10691","DOI":"10.7717\/peerj.10691","volume":"9","author":"Y Hu","year":"2021","unstructured":"Hu Y et al. The association between serum uric acid and diabetic complications in patients with type 2 diabetes mellitus by gender: a cross-sectional study. PeerJ. 2021;9:e10691.","journal-title":"PeerJ."},{"issue":"5","key":"9904_CR47","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jhep.2008.11.021","volume":"50","author":"Y Li","year":"2009","unstructured":"Li Y et al. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol. 2009;50(5):1029-34.","journal-title":"J Hepatol."},{"issue":"1","key":"9904_CR48","first-page":"53","volume":"22","author":"P Liu","year":"2014","unstructured":"Liu P, Ma F, Lou H, Zhu Y, Chen Y. Relationship between normal serum uric acid levels and nonalcoholic fatty liver disease in postmenopausal women. Zhonghua Gan Zang Bing Za Zhi. 2014;22(1):53-7. Chinese.","journal-title":"Zhonghua Gan Zang Bing Za Zhi."},{"key":"9904_CR49","doi-asserted-by":"publisher","first-page":"393628","DOI":"10.1155\/2014\/393628","volume":"2014","author":"W Cai","year":"2014","unstructured":"Cai W et al. The prevalence of nonalcoholic fatty liver disease and relationship with serum uric acid level in Uyghur population. Sci World J. 2014;2014:393628.","journal-title":"Sci World J."},{"key":"9904_CR50","first-page":"S114","volume":"46","author":"R Catanzaro","year":"2014","unstructured":"Catanzaro R et al. The relationship between serum uric acid and non alcoholic fatty liver disease: a cross-sectional retrospective study. Dig Liver Dis. 2014;46:S114.","journal-title":"Dig Liver Dis."},{"issue":"1","key":"9904_CR51","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s41043-021-00247-w","volume":"40","author":"G Chao","year":"2021","unstructured":"Chao G, Chen L. Study on the independent effect of thyroid hormone based on uric acid level on NAFLD. J Health Populat Nutr. 2021;40(1):21.","journal-title":"J Health Populat Nutr."},{"key":"9904_CR52","doi-asserted-by":"publisher","first-page":"2763093","DOI":"10.1155\/2019\/2763093","volume":"2019","author":"Y Chen","year":"2019","unstructured":"Chen Y et al. Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease according to Different Menstrual Status Groups. Canadian J Gastroenterol Hepatol. 2019;2019:2763093.","journal-title":"Canadian J Gastroenterol Hepatol."},{"issue":"1","key":"9904_CR53","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5009\/gnl14444","volume":"10","author":"HC Cho","year":"2016","unstructured":"Cho HC. Prevalence and Factors Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Korean Population. Gut Liver. 2016;10(1):117-25.","journal-title":"Gut Liver."},{"issue":"6","key":"9904_CR54","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1080\/14397595.2017.1300117","volume":"27","author":"L Cui","year":"2017","unstructured":"Cui L et al. Prevalence and risk factors of hyperuricemia: results of the Kailuan cohort study. Modern Rheumatol. 2017;27(6):1066-1071.","journal-title":"Modern Rheumatol."},{"issue":"5","key":"9904_CR55","doi-asserted-by":"publisher","first-page":"107874","DOI":"10.1016\/j.jdiacomp.2021.107874","volume":"35","author":"Y Cui","year":"2021","unstructured":"Cui Y et al. Serum uric acid is positively associated with the prevalence of nonalcoholic fatty liver in non-obese type 2 diabetes patients in a Chinese population. J Diabetes Complicat. 2021;35(5):107874.","journal-title":"J Diabetes Complicat."},{"key":"9904_CR56","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/CEG.S253619","volume":"13","author":"S Golmohammadi","year":"2020","unstructured":"Golmohammadi S et al. Prevalence and Risk Factors of Hyperuricemia in Patients with Chronic Kidney Disease and Non-Alcoholic Fatty Liver. Clin Exp Gastroenterol. 2020;13:299-304.","journal-title":"Clin Exp Gastroenterol."},{"issue":"6","key":"9904_CR57","first-page":"9376","volume":"10","author":"MY Hu","year":"2017","unstructured":"Hu MY, Liu JB, Zhou CH, Li XL. Analysis of the interaction effects among the risk factors for hyperuricaemia in adults: a cross-sectional survey in Guilin, China. Int J Clin Exp Med. 2017;10(6):9376\u20139386.","journal-title":"China. Int J Clin Exp Med."},{"issue":"4","key":"9904_CR58","doi-asserted-by":"publisher","first-page":"e019974","DOI":"10.1136\/bmjopen-2017-019974","volume":"8","author":"X-Y Hu","year":"2018","unstructured":"Hu X-Y et al. Risk factors and biomarkers of non-alcoholic fatty liver disease: an observational cross-sectional population survey. BMJ Open. 2018;8(4):e019974.","journal-title":"BMJ Open."},{"issue":"6","key":"9904_CR59","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3109\/03009741003742797","volume":"39","author":"C-F Kuo","year":"2010","unstructured":"Kuo C-F et al. Gout and risk of non-alcoholic fatty liver disease. Scandinavian J Rheumatol. 2010;39(6):466-71.","journal-title":"Scandinavian J Rheumatol."},{"issue":"6","key":"9904_CR60","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.diabet.2009.04.011","volume":"35","author":"K Lee","year":"2009","unstructured":"Lee K. Relationship between uric acid and hepatic steatosis among Koreans. Diab Metab. 2009;35(6):447-51.","journal-title":"Diab Metab."},{"issue":"5","key":"9904_CR61","first-page":"444","volume":"51","author":"Y Li","year":"2017","unstructured":"Li Y et al. Study about the risk factors of non-alcoholic fatty liver disease among people aged over 60 years old in Suzhou. Zhonghua Yu Fang Yi Xue Za Zhi. 2017;51(5):444-446.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi."},{"issue":"11","key":"9904_CR62","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.3390\/ijerph19116424","volume":"19","author":"C Liu","year":"2022","unstructured":"Liu C et al. Conjunctional Relationship between Serum Uric Acid and Serum Nickel with Non-Alcoholic Fatty Liver Disease in Men: A Cross-Sectional Study. Int J Environ Res Public Health. 2022;19(11):6424.","journal-title":"Int J Environ Res Public Health."},{"key":"9904_CR63","doi-asserted-by":"publisher","first-page":"38605","DOI":"10.1038\/srep38605","volume":"6","author":"C-Q Liu","year":"2016","unstructured":"Liu C-Q et al. Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults. Sci Rep. 2016;6:38605.","journal-title":"Sci Rep."},{"issue":"3","key":"9904_CR64","doi-asserted-by":"publisher","first-page":"E104","DOI":"10.1111\/hepr.12734","volume":"47","author":"J Liu","year":"2017","unstructured":"Liu J et al. Relationship of serum uric acid level with non-alcoholic fatty liver disease and its inflammation progression in non-obese adults. Hepatol Res: Official J Japan Soc Hepatol. 2017;47(3):E104-E112.","journal-title":"Hepatol Res: Official J Japan Soc Hepatol."},{"key":"9904_CR65","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2020.08.006","volume":"311","author":"Z Ma","year":"2020","unstructured":"Ma Z et al. Hyperuricemia precedes non-alcoholic fatty liver disease with abdominal obesity moderating this unidirectional relationship: Three longitudinal analyses. Atheroscler. 2020;311:44-51.","journal-title":"Atheroscler."},{"key":"9904_CR66","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fpubh.2020.00220","volume":"8","author":"X Pan","year":"2020","unstructured":"Pan X et al. Risk Prediction for Non-alcoholic Fatty Liver Disease Based on Biochemical and Dietary Variables in a Chinese Han Population.\u201d\u00a0Frontiers in public health. 2020;8:220.","journal-title":"Frontiers Publ Health."},{"issue":"6","key":"9904_CR67","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.metabol.2010.08.005","volume":"60","author":"S Ryu","year":"2011","unstructured":"Ryu S et al. Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men. Metab: Clin Exp. 2011;60(6):860-6.","journal-title":"Metab: Clin Exp"},{"issue":"5","key":"9904_CR68","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s10067-018-4391-9","volume":"38","author":"Y Shen","year":"2019","unstructured":"Shen Y et al. Prevalence and risk factors associated with hyperuricemia among working population at high altitudes: a cross-sectional study in Western China. Clin Rheumatol. 2019;38(5):1375-1384.","journal-title":"Clin Rheumatol."},{"issue":"4","key":"9904_CR69","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jfma.2012.11.014","volume":"114","author":"M-H Shih","year":"2015","unstructured":"Shih M-H et al. Association between serum uric acid and nonalcoholic fatty liver disease in the US population. J Formosan Med Assoc = Taiwan yi zhi. 2015;114(4):314-20.","journal-title":"J Formosan Med Assoc = Taiwan yi zhi."},{"key":"9904_CR70","doi-asserted-by":"publisher","first-page":"6687626","DOI":"10.1155\/2022\/6687626","volume":"2022","author":"Y Tang","year":"2022","unstructured":"Tang Y et al. No Evidence for a Causal Link between Serum Uric Acid and Nonalcoholic Fatty Liver Disease from the Dongfeng-Tongji Cohort Study. Oxidat Med Cell Longev. 2022;2022:6687626.","journal-title":"Oxidat Med Cell Longev."},{"key":"9904_CR71","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/1756-0500-4-315","volume":"4","author":"T-H Tung","year":"2011","unstructured":"Tung T-H et al. Clinical correlation of nonalcoholic fatty liver disease in a Chinese taxi drivers population in Taiwan: Experience at a teaching hospital. BMC Res Notes. 2011;4:315.","journal-title":"BMC Res Notes."},{"key":"9904_CR72","doi-asserted-by":"publisher","first-page":"e13022","DOI":"10.7717\/peerj.13022","volume":"10","author":"M Wang","year":"2022","unstructured":"Wang M et al. A combined association of serum uric acid, alanine aminotransferase and waist circumference with non-alcoholic fatty liver disease: a community-based study. PeerJ. 2022;10:e13022.","journal-title":"PeerJ."},{"issue":"8","key":"9904_CR73","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.exger.2013.05.059","volume":"48","author":"Z Wang","year":"2013","unstructured":"Wang Z et al. Prevalence and associated metabolic factors of fatty liver disease in the elderly. Exp Gerontol. 2013;48(8):705-9.","journal-title":"Exp Gerontol."},{"key":"9904_CR74","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fendo.2020.00179","volume":"11","author":"F Wei","year":"2020","unstructured":"Wei F et al. Higher Serum Uric Acid Level Predicts Non-alcoholic Fatty Liver Disease: A 4-Year Prospective Cohort Study. Front Endocrinol. 2020;11:179.","journal-title":"Front Endocrinol."},{"issue":"17","key":"9904_CR75","doi-asserted-by":"publisher","first-page":"e802","DOI":"10.1097\/MD.0000000000000802","volume":"94","author":"S-J Wu","year":"2015","unstructured":"Wu S-J et al. Association between sex-specific serum uric acid and non-alcoholic fatty liver disease in Chinese adults: a large population-based study. Med. 2015;94(17):e802.","journal-title":"Med."},{"issue":"1","key":"9904_CR76","first-page":"12","volume":"73","author":"T Yamada","year":"2010","unstructured":"Yamada T et al. Elevated serum uric acid is an independent risk factor for nonalcoholic fatty liver disease in Japanese undergoing a health checkup. Acta Gastro-enterologica Belgica. 2010;73(1):12-7.","journal-title":"Acta Gastro-enterologica Belgica."},{"key":"9904_CR77","doi-asserted-by":"publisher","first-page":"821689","DOI":"10.3389\/fendo.2022.821689","volume":"13","author":"C Yang","year":"2022","unstructured":"Yang C et al. A Bidirectional Relationship Between Hyperuricemia and Metabolic Dysfunction-Associated Fatty Liver Disease. Frontiers Endocrinol. 2022;13:821689.","journal-title":"Frontiers Endocrinol."},{"issue":"5","key":"9904_CR78","doi-asserted-by":"publisher","first-page":"e0177249","DOI":"10.1371\/journal.pone.0177249","volume":"12","author":"C Yang","year":"2017","unstructured":"Yang C et al. Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study. PloS One. 2017;12(5):e0177249.","journal-title":"PloS One."},{"issue":"1","key":"9904_CR79","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12967-018-1657-6","volume":"16","author":"H Yang","year":"2018","unstructured":"Yang H et al. Joint associations of serum uric acid and ALT with NAFLD in elderly men and women: a Chinese cross-sectional study. J Transl Med. 2018;16(1):285.","journal-title":"J Transl Med."},{"issue":"33","key":"9904_CR80","doi-asserted-by":"publisher","first-page":"e26946","DOI":"10.1097\/MD.0000000000026946","volume":"100","author":"H Yu","year":"2021","unstructured":"Yu H et al. Relationship between serum uric acid level and nonalcoholic fatty liver disease in type 2 diabetes patients. Med. 2021;100(33):e26946.","journal-title":"Med."},{"issue":"39","key":"9904_CR81","doi-asserted-by":"publisher","first-page":"e8164","DOI":"10.1097\/MD.0000000000008164","volume":"96","author":"X-L Yu","year":"2017","unstructured":"Yu X-L et al. Gender difference on the relationship between hyperuricemia and nonalcoholic fatty liver disease among Chinese: An observational study. Med. 2017;96(39):e8164.","journal-title":"Med."},{"issue":"12","key":"9904_CR82","doi-asserted-by":"publisher","first-page":"e6381","DOI":"10.1097\/MD.0000000000006381","volume":"96","author":"S Zhang","year":"2017","unstructured":"Zhang S et al. Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia. Med. 2017;96(12):e6381.","journal-title":"Med."},{"issue":"1","key":"9904_CR83","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12944-017-0531-5","volume":"16","author":"X Zheng","year":"2017","unstructured":"Zheng X et al. Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults. Lipids Health Dis. 2017;16(1):202.","journal-title":"Lipids Health Dis."},{"issue":"2","key":"9904_CR84","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/03007995.2023.2296967","volume":"40","author":"A Aydin","year":"2024","unstructured":"Aydin A, Goktas Aydin S. Associations of serum uric acid levels and anthropometric parameters with non-alcoholic fatty liver disease in healthy individuals: innovative insights from a cross-sectional study. Curr Med Res Opin. 2024;40(2):209-215.","journal-title":"Curr Med Res Opin."},{"issue":"34","key":"9904_CR85","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.3346\/jkms.2023.38.e267","volume":"38","author":"JM Lee","year":"2023","unstructured":"Lee JM et al. Associations of Serum Uric Acid Level With Liver Enzymes, Nonalcoholic Fatty Liver Disease, and Liver Fibrosis in Korean Men and Women: A Cross-Sectional Study Using Nationally Representative Data. J Korean Med Sci. 2023;38(34):e267.","journal-title":"J Korean Med Sci."},{"issue":"1","key":"9904_CR86","first-page":"15","volume":"16","author":"H Park","year":"2022","unstructured":"Park H et al. Association between serum uric acid level and non-alcoholic fatty liver disease in Koreans. Asian biomedicine: research, reviews and news. 2022;16(1):15-22.","journal-title":"Asian Biomed Res Reviews News."},{"key":"9904_CR87","doi-asserted-by":"publisher","first-page":"e16267","DOI":"10.7717\/peerj.16267","volume":"11","author":"F Zhou","year":"2023","unstructured":"Zhou F et al. Association between serum ferritin and uric acid levels and nonalcoholic fatty liver disease in the Chinese population. PeerJ. 2023;11:e16267.","journal-title":"PeerJ."},{"issue":"2","key":"9904_CR88","first-page":"662","volume":"17","author":"JUA Khan","year":"2023","unstructured":"Khan JUA et al. Association Between Serum Uric Acid and Nonalcoholic Fatty Liver Disease: A Case Control Study. PJMHS. 2023;17(2):662-663.","journal-title":"PJMHS."},{"issue":"12","key":"9904_CR89","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1016\/j.numecd.2024.09.015","volume":"34","author":"W Chen","year":"2024","unstructured":"Chen W et al. Serum uric acid and mortality in metabolic dysfunction-associated steatotic liver disease: Subgroup differences. Nutrition, metabolism, and cardiovascular diseases: NMCD. 2024;34(12):2771-2778.","journal-title":"Nutr Metab Cardiovasc Dis: NMCD."},{"issue":"1","key":"9904_CR90","doi-asserted-by":"publisher","first-page":"18547","DOI":"10.1038\/s41598-024-69411-6","volume":"14","author":"Y Huang","year":"2024","unstructured":"Huang Y et al. Baseline and change in serum lipid and uric acid level over time and incident of nonalcoholic fatty liver disease (NAFLD) in Chinese adults. Sci Rep. 2024;14(1):18547.","journal-title":"Sci Rep."},{"issue":"1","key":"9904_CR91","doi-asserted-by":"publisher","first-page":"8944","DOI":"10.1038\/s41598-025-93738-3","volume":"15","author":"X Zhou","year":"2025","unstructured":"Zhou, X et al. Relationship between serum uric acid levels and metabolism associated fatty liver disease in postmenopausal women based on NHANES 2017-2020. Sci Rep. 2025 15(1):8944.","journal-title":"Sci Rep."},{"key":"9904_CR92","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.2147\/DMSO.S476045","volume":"17","author":"S Ren","year":"2024","unstructured":"Ren S, Chen S, Huang J, Yu R, Wu Y, Peng XE. Association Between Serum Uric Acid Levels and Metabolic-Associated Fatty Liver Disease\u00a0in Southeast China: A Cross-Sectional Study. Diabetes Metab Syndr Obes. 2024;17:3343-3354.","journal-title":"Diabetes Metab Syndr Obes."},{"issue":"1","key":"9904_CR93","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1186\/s12889-025-21943-w","volume":"25","author":"Q He","year":"2025","unstructured":"He Q, Liu X, Ding G, Wang Y, Luo X, Cao W, Xing W. The relationship between serum uric acid level and non-alcoholic fatty liver disease in northern China: a retrospective cohort study. BMC Public Health. 2025;25(1):718.","journal-title":"BMC Public Health."},{"issue":"1","key":"9904_CR94","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1038\/s41598-025-90590-3","volume":"15","author":"J Xu","year":"2025","unstructured":"Xu J, Deng M, Weng Y, Feng H, He X. Cross-sectional study on the association between serum uric acid levels and non-alcoholic fatty liver disease in an elderly population. Sci Rep. 2025;15(1):5678.","journal-title":"Sci Rep."},{"issue":"2","key":"9904_CR95","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s10620-024-08808-9","volume":"70","author":"Y Li","year":"2025","unstructured":"Li Y, Ma X, Cui S, Jiang G, Jia J, Ge X, Cao L. Association Between Serum Uric Acid and Non-alcoholic Fatty Liver Disease in Non-obese Young Population: A Prospective Cohort Study. Dig Dis Sci. 2025;70(2):825-834.","journal-title":"Dig Dis Sci."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09904-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09904-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09904-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:04:18Z","timestamp":1790899458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-09904-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["9904"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-09904-w","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Human Ethics and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflict of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}